Annovis Bio, Inc. (ANVS)
NYSE: ANVS · IEX Real-Time Price · USD
11.90
-0.13 (-1.08%)
At close: Mar 28, 2024, 4:00 PM
12.15
+0.25 (2.10%)
After-hours: Mar 28, 2024, 7:54 PM EDT

Annovis Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20222021202020192018
Net Income
-25.33-14.49-5.46-0.99-0.71
Share-Based Compensation
9.154.71.860.010.08
Other Operating Activities
-1.140.66-0.370.510.07
Operating Cash Flow
-17.31-9.13-3.97-0.48-0.56
Share Issuance / Repurchase
046.7412.0400
Debt Issued / Paid
0000.530
Other Financing Activities
----0.090.24
Financing Cash Flow
046.7412.040.440.25
Net Cash Flow
-17.3137.618.07-0.03-0.31
Free Cash Flow
-17.31-9.13-3.97-0.48-0.56
Free Cash Flow Per Share
-2.12-1.20-0.63-1.69-2.01
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).